Salix Sues Novel Labs Over Bowel Cleanser Patent

Law360, New York (May 15, 2008, 12:00 AM EDT) -- Salix Pharmaceuticals Inc. has hit Novel Laboratories Inc. with a patent suit in a bid to maintain control over the U.S. market for MoviPrep, which is used for bowel cleansing prior to colonoscopies, intestinal surgery and barium enema X-ray exams.

Salix, Norgine BV and Norgine Europe BV filed their complaint on Wednesday in the U.S. District Court for the District of New Jersey. In December 2005, Salix struck a deal with Amsterdam-based Norgine under which Salix was granted the exclusive right to sell MoviPrep in the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.